Company research
Scorpius Holdings, Inc.
CIK 1476963Updated Sep 24, 2026
SecuritySCPX · OTC · equity
Historical securities (1)
SCPXD · OTC · equity · closed Aug 1, 2024Name history
NightHawk Biosciences, Inc. · through Jan 30, 2024HEAT BIOLOGICS, INC. · through Apr 25, 2022
SCPX price & chart
Loading TradingView…
OTC:SCPX on TradingView ↗About the company
We are a contract development and manufacturing organization (“CDMO”) that provides a comprehensive range of biologics manufacturing services from process development to Current Good Manufacturing Practices (“cGMP”) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. Scorpius pairs cGMP biomanufacturing and quality control expertise with cutting edge capabilities in immunoassays, molecular assays, and bioanalytical methods to support the production of cell- and gene-based therapies as well as large molecule biologics. Our services include clinical and commercial drug substance manufacturing, release and stability testing and variety of process development services, including upstream and downstream development and optimization, analytical method development, cell line development, testing and characterization. Our San Antonio, TX facility commenced operations in October 2022.
In the news
No coverage from other publishers is available.
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Items 1.01, 2.03, 3.02, 9.01
Completion of Acquisition or Disposition of Assets · Triggering Events That Accelerate or Increase a Direct Financial Obligation
Items 2.01, 2.04, 9.01
10-Q filing
Show 5 more recent filings
SCHEDULE 13G/A - filed by 3i, LP regarding Scorpius Holdings, Inc.
Completion of Acquisition or Disposition of Assets · Triggering Events That Accelerate or Increase a Direct Financial Obligation
Items 2.01, 2.04, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Items 1.01, 2.03, 3.02, 9.01
10-Q filing
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities
Items 1.01, 2.03, 3.02, 9.01
Financials
FY 2024 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 39,177,719Source | 51,037,627Source | 104,396,912Source | 120,961,233Source |
| Property, Plant and Equipment, NetUSD | 12,315,460Source | 17,587,337Source | 20,480,375Source | 2,158,479Source |
| GoodwillUSD | — | — | 3,301,959Source | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,027,997Source | 184,925Source | 8,434,554Source | 8,053,879Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 143,469Source | 375,192Source | 81,456Source | 66,049Source |
| Inventory, NetUSD | 198,688Source | 909,158Source | — | — |
| Assets, CurrentUSD | 3,260,955Source | 4,760,859Source | 50,054,259Source | 99,331,370Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,755,658Source | 817,029Source | 3,575,541Source | 2,886,520Source |
| Operating Lease, Right-of-Use AssetUSD | 4,803,361Source | 6,041,439Source | 6,005,147Source | 1,782,884Source |
| Other Assets, NoncurrentUSD | — | — | — | 19,471,384Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 37,500,241Source | 22,743,292Source | 31,960,244Source | 8,927,662Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 1,017Source | 5,244Source | 5,126Source | 5,055Source |
| Additional Paid in CapitalUSD | 293,253,163Source | 285,713,238Source | 283,019,456Source | 278,890,153Source |
| Retained Earnings (Accumulated Deficit)USD | -287,178,670Source | -254,370,827Source | -209,153,659Source | -165,718,953Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 224,110Source | 48,877Source | 51,924Source | -67,941Source |
| Stockholders' Equity Attributable to ParentUSD | 6,299,620Source | 31,396,532Source | 73,922,847Source | 113,108,314Source |
| Liabilities and EquityUSD | 39,177,719Source | 51,037,627Source | 104,396,912Source | 120,961,233Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 24,289,095Source | 10,100,138Source | 18,037,323Source | 4,720,745Source |
| Operating Lease, Liability, CurrentUSD | 474,972Source | 524,208Source | 490,378Source | 350,343Source |
| Accounts Payable, CurrentUSD | 3,227,313Source | 4,109,947Source | 4,424,053Source | 922,782Source |
| Operating Lease, Liability, NoncurrentUSD | 3,036,157Source | 3,597,014Source | 3,079,887Source | 1,060,856Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | — | 215,937Source |
| Other Liabilities, NoncurrentUSD | — | — | — | 53,530Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -4,622,142Source | -3,102,197Source | -1,486,179Source | -1,074,743Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 2,160,258Source | 2,201,861Source | 4,301,922Source | 2,419,676Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 1,200,000Source | 2,400,000Source | 44,300,000Source | 96,400,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | 215,937Source |
| Short-term InvestmentsUSD | 135,143Source | 2,206,555Source | 35,837,309Source | 88,324,922Source |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -34,327,788Source | -46,833,186Source | -43,862,197Source | -35,400,807Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 7,154,149Source | 6,474,256Source | 2,115,015Source | 607,667Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,033,718Source | 2,628,276Source | 4,085,737Source | 6,168,981Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -232,911Source | 293,698Source | 15,967Source | -110,111Source |
| Increase (Decrease) in InventoriesUSD | -710,470Source | 909,158Source | -5,844,000Source | — |
| Increase (Decrease) in Accounts PayableUSD | -882,427Source | -116,908Source | 3,299,326Source | -126,937Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -26,006,641Source | -31,532,595Source | -5,700,364Source | -38,128,906Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | -2,719,899Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 1,214,170Source | 32,236,595Source | 10,991,604Source | 9,770,265Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 875,155Source | 1,985,557Source | 20,117,998Source | 1,904,713Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 25,636,356Source | -8,952,074Source | -4,906,941Source | 25,490,349Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 843,072Source | -8,249,629Source | 380,675Source | -2,878,011Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 1,027,997Source | 184,925Source | 8,434,554Source | 8,053,879Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | — | 1,091,250Source | 1,030,625Source | — |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 1,200,000Source | 2,400,000Source | 44,300,000Source | 96,400,000Source |
| DepreciationUSD | 4,900,000Source | 4,600,000Source | 1,800,000Source | 422,496Source |
| Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of TaxUSD | — | 1,467,451Source | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -563,865Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | -560,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 21,130,879Source | 16,828,229Source |
| GoodwillUSD | — | — | 3,301,959Source | — |
| Goodwill, Impairment LossUSD | — | 3,873,079Source | — | 1,452,338Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | 3,500,000Source | 2,366,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -34,327,788Source | -41,762,479Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | -5,070,707Source | — | — |
| Income Tax Expense (Benefit)USD | — | -571,120Source | -3,288,937Source | -145,974Source |
| Inventory Write-downUSD | 0Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -32,807,843Source | -45,217,168Source | -43,434,706Source | -35,071,468Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -1,519,945Source | -1,616,018Source | -427,491Source | -329,339Source |
| Nonoperating Income (Expense)USD | -727,527Source | -301,427Source | -1,462,396Source | -127,742Source |
| Operating ExpensesUSD | — | — | — | 37,531,845Source |
| Other Nonoperating Income (Expense)USD | -746,834Source | -104,822Source | -759,235Source | -965,816Source |
| Proceeds from Issuance of Common StockUSD | 22,006,353Source | 65,624Source | 59,692Source | 26,304,282Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | 27,261Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 6,243,022Source | 6,994,838Source | 6,383,169Source | 2,112,806Source |
| Unrealized Gain (Loss) on InvestmentsUSD | 999Source | 123,019Source | -1,701,443Source | -842,538Source |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cost of RevenueUSD | 3,196,245Source | 2,736,998Source | 6,401,018Source | — |
| Selling, General and Administrative ExpenseUSD | 21,570,874Source | 26,170,221Source | — | — |
| Operating Income (Loss)USD | -33,600,261Source | -42,032,172Source | -45,688,738Source | -35,419,039Source |
| Other Nonoperating Income (Expense)USD | -746,834Source | -104,822Source | -759,235Source | -965,816Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -34,327,788Source | -42,333,599Source | -47,151,134Source | -35,546,781Source |
| Income Tax Expense (Benefit)USD | — | -571,120Source | -3,288,937Source | -145,974Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -1,519,945Source | -1,616,018Source | -427,491Source | -329,339Source |
| Net Income (Loss) Attributable to ParentUSD | -32,807,843Source | -45,217,168Source | -43,434,706Source | -35,071,468Source |
| Earnings Per Share, BasicUSD per share | -13.04Source | -1.74Source | -1.7Source | -1.41Source |
| Earnings Per Share, DilutedUSD per share | -13.04Source | -1.74Source | -1.7Source | -1.49Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 2,515,742Source | 26,046,594Source | 25,606,326Source | 24,913,942Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 2,515,742Source | 26,046,594Source | 25,606,326Source | 24,913,942Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | — | 1,091,250Source | 1,030,625Source | — |
| Costs and ExpensesUSD | 39,843,283Source | 49,027,010Source | 52,071,907Source | — |
| General and Administrative ExpenseUSD | — | — | 21,130,879Source | 16,828,229Source |
| Goodwill, Impairment LossUSD | — | 3,873,079Source | — | 1,452,338Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -34,327,788Source | -41,762,479Source | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | -13.04Source | -1.54Source | — | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | -13.04Source | -1.54Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | -5,070,707Source | — | — |
| Interest Income (Expense), Nonoperating, NetUSD | -953,173Source | -776,838Source | — | — |
| Interest Income, OtherUSD | 22,230Source | 457,189Source | 987,247Source | 815,316Source |
| Nonoperating Income (Expense)USD | -727,527Source | -301,427Source | -1,462,396Source | -127,742Source |
| Operating ExpensesUSD | — | — | — | 37,531,845Source |
| Other IncomeUSD | 1,107,501Source | — | — | — |
| Research and Development ExpenseUSD | 14,326,918Source | 20,119,791Source | 23,461,400Source | 18,821,278Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 6,243,022Source | 6,994,838Source | 6,383,169Source | 2,112,806Source |